First and only commercially approved focused ultrasound non-invasive therapeutic application
- Over 5 years experience post PMA using MR guided focused ultrasound
- Over 6000 women treated globally with improved symptom relief and patient satisfaction
- Non-invasive uterus-sparing procedure
- No anesthesia and no hospitalization required
- Improved quality of life for patients, back to normal activity the next day
Approved by the U.S. Food and Drug Administration in 2004 as an incisionless treatment alternative for symptomatic uterine fibroids and CE approved for adenomyosis, ongoing research is being conducted in oncology applications: pain palliation of bone metastases (CE approved), prostate and breast cancer.
For more information please contact us.
